自然产品和COVID-19的药物目标:科学已经进展了多远?
Kannan Raman1, Kalirajan Rajagopal1, B Ramesh2
1Department of Pharmaceutical Chemistry, JSS College of Pharmacy (JSS Academy of Higher Education & Research), Ooty, The Nilgiris, Tamil Nadu India.
Annals of medicine and surgery (2012)
|June 26, 2023
概括
天然产品在治疗严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 方面表现有前途. 这项研究探讨了向病毒蛋白的天然化合物,为2019年冠状病毒病提供了潜在的新疗法.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 2019年底严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 的出现导致了2019年冠状病毒疾病 (COVID-19) 的全球大流行.
- 由于SARS-CoV-2的快速传播和高死亡率,迫切需要有效的治疗方法,目前可用的选择有限.
- 由于药物开发过程漫长,重新利用现有药物和探索天然产品是关键策略.
研究的目的:
- 研究天然产品作为抗病毒剂对抗SARS-CoV-2的潜力.
- 为了确定特定的病毒标和具有抑制活性的天然化合物.
- 探索COVID-19治疗的新型治疗途径.
主要方法:
- 利用体研究来评估天然产品与SARS-CoV-2蛋白质的结合亲和力.
- 专注于关键的病毒蛋白,包括非结构蛋白 (PLpro,Mpro,RdRp) 和结构蛋白 (尖端蛋白).
- 检查了血管酶转化酶2 (ACE2) 受体在病毒进入中的作用,作为潜在的治疗点.
主要成果:
- 几种天然产品对关键的SARS-CoV-2蛋白质表现出显著的结合亲和力,这表明具有抑制潜力.
- 在分析表明,天然化合物可以抑制病毒非结构和结构蛋白.
- 该研究确定了特定的天然化合物作为进一步治疗SARS-CoV-2的治疗研究的有希望的候选人.
结论:
- 天然产品代表了开发新抗病毒疗法对抗SARS-CoV-2的可行来源.
- 用天然化合物向病毒蛋白和ACE2受体为COVID-19药物开发提供了一个有前途的战略.
- 对天然化合物的抗病毒特性进行进一步的研究是有效的SARS-CoV-2治疗的必要条件.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.3K
相关概念视频
01:26Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K
01:26Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
01:28Structure-Activity Relationships and Drug Design
794
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
794
01:24Principles of Drug Action
6.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.1K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K